Test Order - Bordetella Pertussis Identification or Confirmation
Pre-Approval Required
No
Supplemental Information or Form
- Pure,
viable subculture
- Completed
submittal form with 2 patient identifiers (e.g. name and date of birth),
collection date and source, a brief but complete patient history, cultural
history and submitting laboratoryās findings
- Documentation
that indicates the role of this isolate in clinical disease
- Form LAB 446
Performed on Specimens From
None
Acceptable Sample/Specimen Type for Testing
Suspected
Bordetella pertussis isolate
Minimum Volume Required
None
Storage & Preservation of Sample/Specimen Prior to Shipping
None
Transport
Tubed
agar medium with a secure screw cap, labeled with patientās name.
Alternatively, blocks of Regan-Lowe or Bordet-Gengou agar may be
aseptically be cut from plates and then inserted into tubed agar medium of
another type with a secure screw cap.
Sample/Specimen Labeling
None
Shipping Instructions which Include Specimen Handling Requirements
- Grow
isolate under appropriate conditions prior to shipping.
- Ship
at ambient temperature using appropriate DOT/IATA approved shipping
procedures.
Test Methodology
As
needed - Biochemical testing, species specific slide agglutination, Gene
Sequencing by PCR, and/ or MALDI-TOF mass spectrometry
Turnaround Time
Two weeks
Interferences & Limitations
Mixed
or nonviable culture
Additional Information
Please
contact the MDL Vaccine
Preventable Pathogens & Molecular Bacteriology Unit (VPP & MBU) for special consideration if any of the above
criteria cannot be met.
MDL Points of Contact